Search research articles
Contact Us
Filters
Showing results (11-20 of 99) with videos related to
Page
of 10
Sort By:
United European Gastroenterology Journal
|
October 6, 2018
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, et al.
Acta Gastro-Enterologica Belgica
|
July 11, 2007
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study
Eduard Louis, Jacques Boverie, Olivier Dewit, et al.
Gut
|
January 19, 2007
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire, Maja Noman, Gert Van Assche, et al.
Journal of Crohn'S & Colitis
|
May 21, 2014
Clinical trials in luminal Crohn's disease: a historical perspective
Pieter Hindryckx, Filip Baert, Ailsa Hart, et al.
Journal of Crohn'S & Colitis
|
April 28, 2015
Clinical trials in ulcerative colitis: a historical perspective
Pieter Hindryckx, Filip Baert, Ailsa Hart, et al.
Clinical Chemistry and Laboratory Medicine
|
October 12, 2013
Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics
Matthijs Oyaert, Charlotte Trouvé, Filip Baert, et al.
Journal of Digestive Diseases
|
March 20, 2021
Conservative management of spontaneous intra-abdominal abscess in Crohn's disease: Outcome and prognostic factors
Bruno Waked, Tom Holvoet, Jeroen Geldof, et al.
Updates in Surgery
|
June 15, 2026
Perioperative risk factors for disease recurrence following ileocecal resection in Crohn's disease: implications for early immunosuppressive therapy
Martijn Depuydt, Filip Baert, Esther Bossuyt, et al.
The New England Journal of Medicine
|
February 14, 2003
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
Filip Baert, Maja Noman, Severine Vermeire, et al.
Journal of Crohn'S & Colitis
|
July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis
Konstantinos Papamichael, Filip Baert, Sophie Tops, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 99) with videos related to
Sort By:
Page
of 10
United European Gastroenterology Journal
|
October 6, 2018
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, et al.
Acta Gastro-Enterologica Belgica
|
July 11, 2007
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study
Eduard Louis, Jacques Boverie, Olivier Dewit, et al.
Gut
|
January 19, 2007
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire, Maja Noman, Gert Van Assche, et al.
Journal of Crohn'S & Colitis
|
May 21, 2014
Clinical trials in luminal Crohn's disease: a historical perspective
Pieter Hindryckx, Filip Baert, Ailsa Hart, et al.
Journal of Crohn'S & Colitis
|
April 28, 2015
Clinical trials in ulcerative colitis: a historical perspective
Pieter Hindryckx, Filip Baert, Ailsa Hart, et al.
Clinical Chemistry and Laboratory Medicine
|
October 12, 2013
Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics
Matthijs Oyaert, Charlotte Trouvé, Filip Baert, et al.
Journal of Digestive Diseases
|
March 20, 2021
Conservative management of spontaneous intra-abdominal abscess in Crohn's disease: Outcome and prognostic factors
Bruno Waked, Tom Holvoet, Jeroen Geldof, et al.
Updates in Surgery
|
June 15, 2026
Perioperative risk factors for disease recurrence following ileocecal resection in Crohn's disease: implications for early immunosuppressive therapy
Martijn Depuydt, Filip Baert, Esther Bossuyt, et al.
The New England Journal of Medicine
|
February 14, 2003
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
Filip Baert, Maja Noman, Severine Vermeire, et al.
Journal of Crohn'S & Colitis
|
July 13, 2016
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis
Konstantinos Papamichael, Filip Baert, Sophie Tops, et al.
Page
of 10